GF
PETX

Gabelli Funds’s Aratana Therapeutics, Inc. PETX Stock Holding History

Gabelli Funds’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-816,238
Closed -$4.21M – 1185
2019
Q2 		$4.21M Buy
+816,238
New +$3.67M 0.03% 579

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Gabelli Funds's PETX Position: Q3 2019 in Review

Gabelli Funds sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 816,238 shares — an estimated $4.21M sold.

Gabelli Funds first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $4.21M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Gabelli Funds reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Gabelli Funds sold 816,238 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $4.21M.
  • Gabelli Funds first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
  • Gabelli Funds's Aratana Therapeutics, Inc. position peaked at $4.21M in Q2 2019.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Gabelli Funds's 13F filing for Q3 2019, filed 1 Nov 2019.